Penn Capital Management’s Core Laboratories CLB Stock Holding History

Penn Capital Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-50,825	Closed	-$1.01M	–	185
2022 Q2	$1.01M	Buy	+50,825	New	+$1.35M	0.11%	141
2020 Q1	–	Sell	-86,489	Closed	-$3.26M	–	196
2019 Q4	$3.26M	Sell	86,489 -26,631	-24%	-$1.2M	0.34%	122
2019 Q3	$5.27M	Buy	+113,120	New	+$5.26M	0.55%	68

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

Penn Capital Management's CLB Position: Q3 2022 in Review

Penn Capital Management sold out of Core Laboratories (CLB) in Q3 2022, closing a stake of 50,825 shares — an estimated $1.01M sold.

Penn Capital Management first reported a position in CLB in Q3 2019 and held it in 3 quarters. The position peaked at $5.27M in Q3 2019. 162 funds tracked by Wall St. Rank hold CLB as of Q3 2022.

Penn Capital Management reported no remaining Core Laboratories position as of Q3 2022 after selling out during the quarter.
Penn Capital Management sold 50,825 Core Laboratories shares in Q3 2022, an estimated $1.01M.
Penn Capital Management first reported a position in Core Laboratories in Q3 2019 and held it in 3 quarters.
Penn Capital Management's Core Laboratories position peaked at $5.27M in Q3 2019.
162 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2022.

Based on Penn Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.